Abbott Laboratories
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical De…
Medical - Devices
US, North Chicago [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
1
Financial Health
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Current Ratio | -2.56 | 1.60 | 1.64 | |
| Debt/Assets | n.A. | n.A. | n.A. | |
| Debt/Equity | n.A. | n.A. | n.A. | |
| Net Debt/EBITDA | 70.74 | 5.73 | 3.35 | |
| Naive Interpretation | member | |||
2
Per Share
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | 0.54 | 22.38 | 22.26 | |
| Cash | -8.63 | 3.84 | 4.20 | |
| Capex | 47.28 | -0.23 | -0.44 | |
| Free Cash Flow | -72.54 | 0.36 | 1.32 | |
| Revenue | -2.70 | 5.75 | 5.91 | |
| Naive Interpretation | member | |||
3
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Margin | 8.37 | 0.56 | 0.51 | |
| Operating Margin | -20.05 | 0.15 | 0.18 | |
| ROA | -22.36 | 0.02 | 0.02 | |
| ROE | -23.56 | 0.03 | 0.04 | |
| ROIC | -25.09 | 0.02 | 0.03 | |
| Naive Interpretation | member | |||
4
Valuation
The "Valuation Entry" for the Focus of ABT is permitted for members.
5
Growth
The "Growth Entry" for the Focus of ABT is permitted for members.
6
Leverage & Liquidity